GS PAPER II: Issues relating to development and management of Social Sector/Services relating to Health, Education, Human Resources.

Context: AYUSH 64 found useful in the treatment of mild to moderate COVID-19 infection

• The scientists have found that AYUSH 64, a poly herbal formulation developed by the Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of Ayush is useful in the treatment of asymptomatic, mild and moderate COVID-19 infection as an adjunct to standard care.
• It is worthwhile to mention that initially the drug was developed for Malaria in the year 1980 and now is repurposed for COVID-19.
• AYUSH 64 comprises of Alstonia scholaris (aqueous bark extract), Picrorhiza kurroa (aqueous rhizome extract), Swertia chirata (aqueous extract of whole plant) and Caesalpinia crista (fine-powdered seed pulp).
• It is extensively studied, scientifically developed, safe and effective Ayurveda formulation.
• This medicine is also recommended in National Clinical Management Protocol based on Ayurveda and Yoga which is vetted by National Task Force on COVID-19 Management of ICMR.
• There are several significant beneficial effects of AYUSH 64 on general health, fatigue, anxiety, stress, appetite, general happiness and sleep.

https://pib.gov.in/PressReleasePage.aspx?PRID=1714815

Download PDF